Soluble PD-1 and SPD-L2 unaffected by adalimumab treatment in early RA and associated with presence of anti-CCP and IGM-RF

S.R. Greisen, K. Steengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, B.W. Deleuran

Original language	English
Journal	Annals of the Rheumatic Diseases
Volume	72
Issue number	Suppl. 3
Pages (from-to)	803
Number of pages	1
ISSN	0003-4967
Publication status	Published - 2013

Cite this

In: Annals of the Rheumatic Diseases, Vol. 72, No. Suppl. 3, 2013, p. 803.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

@article{22abf09c1fad4fd88352c575616e7e7f,

title = "Soluble PD-1 and SPD-L2 unaffected by adalimumab treatment in early RA and associated with presence of anti-CCP and IGM-RF",

author = "S.R. Greisen and K. Steengaard-Pedersen and Hetland, {Merete Lund} and Kim H{\o}rslev-Petersen and B.W. Deleuran",

year = "2013",

language = "English",

volume = "72",

pages = "803",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "B M J Group",

number = "Suppl. 3",

}

TY - ABST

T1 - Soluble PD-1 and SPD-L2 unaffected by adalimumab treatment in early RA and associated with presence of anti-CCP and IGM-RF

AU - Greisen, S.R.

AU - Steengaard-Pedersen, K.

AU - Hetland, Merete Lund

AU - Hørslev-Petersen, Kim

AU - Deleuran, B.W.

PY - 2013

Y1 - 2013

M3 - Conference abstract in journal

VL - 72

SP - 803

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 3

ER -